Doesn't really matter with the stock price stuck below $9 whether they earn $2 or $2.5. Investment research and top stock picks from several leading contributors. Investment research and top stock picks from several leading contributors.

Doesn't really matter with the stock price stuck below $9 whether they earn $2 or $2.5. Investment research and top stock picks from several leading contributors. Investment research and top stock picks from several leading contributors. Its also important to note that the stock currently trades below that purchase price of $5. That purchase price was somewhat above the stock price at the time of the announcement as well. The business developments during the last few months sets the stock up for a sustainable rally. Read the full article on Seeking Alpha. Disclosure: Long SGYP. Investment research and top stock picks from several leading contributors.

8/4/2016 · ARATANA THERAP (PETX): Free Stock Analysis Report. HERON THERAPEUT (HRTX): Free Stock Analysis Report. To read this article on Zacks.com click here. Zacks Investment Research. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Visit performance for information about the performance numbers displayed above. Aratana (PETX) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to loss of $0.21 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 246.15%. Check out our PETX stock analysis, current PETX quote, charts, and historical prices for Aratana Theraptcs stock Aratana Therapeutics, Inc. PETX was a big mover last session, as the company saw its shares rise more than 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $3.72-$4.43 in the past one-month time frame, showed a sharp increase yesterday. View Aratana Therapeutics' (NASDAQ:PETX) earnings history, next earnings date and earnings forecasts from top-rated Wall Street analysts at MarketBeat.

Investment research and top stock picks from several leading contributors.

Options are derivative products that allow investors to leverage a high level of stock without having to come up with a large amount of capital and actually purchase the stock itself. Purchasers of call options can take advantage of stock moves without an equal amount of risk, Their average twelve-month price target is $4.73, suggesting that the stock has a possible downside of 3.96%. The high price target for PETX is $5.00 and the low price target for PETX is $4.14. There are currently 4 hold ratings for the stock, resulting in a consensus rating of "Hold." 11/1/2018 · Aratana (PETX) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to The Zacks Personal Finance Channel provides guidance about investing, insurance, retirement planning and taxes so readers can make informed decisions about their PETX - Aratana Therapeutics, Inc., stock quotes, stock charts, news, financials, short interest, message boards, insiders, holders, calendars, competitors, historical

Investment research and top stock picks from several leading contributors.

Investment research and top stock picks from several leading contributors.

The stock has reasonable targets of $10 billion in revenues and a $1.75 EPS. For a few years now, Advanced Micro Devices (AMD) has attempted to reach the inflection point where their chips reached the price and performance that customers…

Investment research and top stock picks from several leading contributors. Investment research and top stock picks from several leading contributors.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Book Value (Per Share) is a widely used stock evaluation measure. Find the latest Book Value (Per Share) for NA (PETX) NA (PETX) Book Value (Per Share) - Zacks.com Book Value is a widely used stock evaluation measure. Find the latest Book Value for NA (PETX)